Abstract GS3-03: A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients (REACT – Randomised EuropeAn celecoxib trial)
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. TPS115-TPS115
◽
Keyword(s):
Keyword(s):
2011 ◽
Vol 79
(5)
◽
pp. 1460-1466
◽
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 589-589
◽
Keyword(s):
2014 ◽
Vol 50
(1)
◽
pp. 23-30
◽
Keyword(s):
2015 ◽
Vol 23
(4)
◽
pp. 1137-1143
◽
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 589-589
Keyword(s):
1991 ◽
Vol 27
(9)
◽
pp. 1137-1140
◽